The Charles A. Sanders Life Sciences Award – “The Charlie” – is an annual award that recognizes “bold and venturesome” innovation and collaboration in clinical oncology research. The Charlie is named in honor of Charles A. Sanders, MD, former Chairman of Glaxo, and Chairman of the Foundation of the National Institutes of Health. Dr. Sanders has been the force behind many innovative life-lengthening and life-saving products. Indeed, he has helped to shape health education and medical research in the United States from his days as chief executive of Massachusetts General Hospital, Harvard University. A renowned scientist, educator, physician, administrator and philanthropist, Dr. Sanders represents the tenets of leadership, innovation and collaboration and patient-centric devotion that the Life Sciences Consortium espouses and seeks to catalyze.
The Spirit of Health Award was created in 2021 to focus attention on the health of those disproportionately affected by cancer and the difference that one person or organization can make through their leadership, vision, passion, and pure drive to connect people and institutions to eliminate disparities. In 2024 it was renamed the Robert A. Ingram Spirit of Health Award to honor the Roundtable’s founding chairman, who died in 2023.
The Award recognizes individuals and organizations who have worked in extraordinary and tireless ways to elevate communities of health, accelerate health equity, bridge the gap of the cancer burden, expand cancer prevention and health education, ensure access to care, and in doing so change the course of numerous lives.
The Research Catalyst Award
The Research Catalyst Award is an award presented by Project Data Sphere to honor individuals and institutions who are using data in new and innovative ways to advance oncology research. Award recipients have a demonstrated track record of breaking down barriers to cancer clinical trial data sharing and leveraging the power of big data to unlock new discoveries and treatments.